Zuffa, LLC, owner of the Ultimate Fighting Championship®, released a
statement today regarding UFC middleweight Rousimar Palhares and light
heavyweight Joey Beltran:
“Rousimar Palhares tested positive for elevated testosterone and Joey Beltran tested positive for nandrolone, following their respective bouts at UFC on FX 6 in Australia. The UFC organization has a strict, consistent policy against the use of any illegal and/or performance-enhancing drugs, stimulants or masking agents. Both athletes have agreed to serve a nine-month suspension retroactive to December 14. They must pass a drug test upon completion of the suspension before receiving clearance to compete again.”
